Guardant Health (GH) Revenue (2017 - 2026)

Guardant Health (GH) has 10 years of Revenue data on file, last reported at $301.7 million in Q1 2026.

• Quarterly Revenue rose 48.26% year-over-year to $301.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 39.56% YoY) and the FY2025 annual result came in at $982.0 million, up 32.88% from the prior year.
• Revenue improved to $301.7 million in Q1 2026 per GH's latest filing, from $281.3 million in the prior quarter.
• The five-year high for Revenue was $301.7 million in Q1 2026, with the low at $96.1 million in Q1 2022.
• Average Revenue over 5 years is $178.6 million, with a median of $168.5 million recorded in 2024.
• Year-over-year, Revenue advanced 17.37% in 2022 and soared 48.26% in 2026.
• Guardant Health's Revenue stood at $126.9 million in 2022, then grew by 22.19% to $155.1 million in 2023, then surged by 30.16% to $201.8 million in 2024, then jumped by 39.37% to $281.3 million in 2025, then advanced by 7.25% to $301.7 million in 2026.
• Business Quant data shows GH's Revenue at $301.7 million in Q1 2026, $281.3 million in Q4 2025, and $265.2 million in Q3 2025.